Et biolase started at speculative buy with $2 stock price target at benchmark 344 rows biolase (biol) stock price prediction is 0.66412784630009 usd.
Continued high demand from new users for dental lasers.
Biolase share price forecast. Spare a thought for those who held biolase, inc. Summary of all time highs, changes and price drops for biolase; On july 23, 2020, the company consummated the sale of an aggregate of 18,000 shares of series f convertible preferred stock, par value $0.001 per share (series f preferred stock) and 45,000,000.
This price target is based on 3 analysts offering 12 month price targets for biolase in the last 3 months. Biolase bulls will hope to hear the company to announce they've not only beaten that estimate, but also to. 12, 2021 at 5:12 p.m.
Monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis Idea only not professional advice biolase reports 70% revenue growth in first quarter 2021; Find the latest biolase, inc.
Press release reported 6 hours ago that biolase reports 46% revenue growth in 2021 thi The company’s stock price has collected 3.90% of gains in the last five trading sessions. According to analyst projections, biol’s forecast low is $2.00 with $3.00 as the target high.
Nasdaq updated dec 3, 2021 8:36 pm biol 0.42 0.01 (3.01%). (biol) stock quote, history, news and other vital information to help you with your stock trading and investing. Shareholders have had an even rougher run lately, with the share price down 46%.
Biolase reports 2q results, shares rise 23% after hours aug. Laser system sales increased 139% consumables and other revenue. Price target in 14 days:
Net revenue grew 70% to $8.1 million with: Biolase reporte in form4 filing that president bought 70,000 shares at. According to the issued ratings of 3 analysts in the last year, the consensus rating for biolase stock is buy based on the current 3 buy ratings for biol.
Biolase inc., which has a market valuation of $79.24 million, is expected to release its quarterly earnings report mar 25, 2021. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash. Biolase stock forecast, bth1 stock price prediction.
During the day the stock fluctuated 20.25% from a day low at $0.40 to a day high of $0.48. 2021 first quarter operating highlights (all comparisons are on a year over year basis): According to analysts' consensus price target of $2.05, biolase has a forecasted upside of 396.4% from its current price of $0.41.
Amount of analyst coverage biolase has received no research coverage in the past 90 days. The biolase stock price gained 1.08% on the last trading day (friday, 3rd dec 2021), rising from $0.41 to $0.41. Learn more on biol's analyst rating history
The price to cash flow ratio or p/cf is price divided by its cash flow per share. The average price target is $2.05, with a high.
0 komentar:
Posting Komentar